Regulatory factor X1-induced down-regulation of transforming growth factor β2 transcription in human neuroblastoma

Chenzhuo Feng1, Zhiyi Zuo

  • 1Department of Anesthesiology, School of Medicine, University of Virginia, Charlottesville, Virginia 22908, USA.

Insights

Regulatory factor X (RFX1) inhibits cell proliferation by decreasing transforming growth factor β2 (TGFβ2) and extracellular signal-regulated kinase (ERK) signaling. RFX1 directly suppresses TGFβ2 transcription, suggesting a role in tumor biology.

Area of Science:

  • Molecular biology
  • Cell biology
  • Cancer research

Background:

  • Regulatory factor X (RFX) proteins are transcription factors with diverse roles.
  • RFX1 is the prototype RFX protein, but its biological functions remain largely unknown.
  • Transforming growth factor β2 (TGFβ2) and extracellular signal-regulated kinase (ERK) signaling pathways are implicated in cell proliferation and cancer development.

Purpose of the Study:

  • To investigate the biological functions of RFX1 in cell proliferation.
  • To elucidate the molecular mechanisms underlying RFX1's effects on cell growth.
  • To explore the potential role of RFX1 in human tumor biology.

Main Methods:

  • Overexpression and down-regulation of RFX1 in human neuroblastoma (SH-SY5Y) and normal neuronal (HCN-1A) cell lines.
  • Measurement of cell proliferation, TGFβ2 levels, and phospho-ERK levels.
  • Analysis of TGFβ2 promoter activity and RFX1 binding using chromatin immunoprecipitation assays.
  • Correlation analysis of RFX1 and TGFβ2 levels in human medulloblastoma tissues.

Main Results:

  • RFX1 overexpression reduced SH-SY5Y cell proliferation, associated with decreased TGFβ2 and phospho-ERK.
  • Exogenous TGFβ2 rescued the proliferation defect and restored phospho-ERK levels in RFX1-overexpressing cells.
  • RFX1 directly bound to the TGFβ2 promoter, inhibiting its activity and subsequently decreasing TGFβ2 expression.
  • RFX1 down-regulation increased TGFβ2 levels in both cell lines, and RFX1 levels were negatively correlated with TGFβ2 in medulloblastoma tissues.

Conclusions:

  • RFX1 inhibits cell proliferation by suppressing the TGFβ2-ERK signaling pathway.
  • RFX1 acts as a transcriptional repressor of TGFβ2.
  • RFX1 may play a significant role in human tumor biology, particularly in cancers where TGFβ signaling is dysregulated.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...